Product Information
WELLBUTRIN XL 300 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $92.4068 per EA under NDC 00187073130. Its NADAC has been published 619 times since Nov 28, 2013.
FDA first approved this application on Aug 28, 2003. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the bupropion hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Bausch Health US LLCNDC
00187073130
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021515FDA Approved
8/28/2003
TE Code
AB3
On Market Since
8/29/2003
Pharmacological Classes
Price Statistics
The NADAC for WELLBUTRIN XL 300 MG TABLET has been published 619 times since Nov 28, 2013, and over the history we have for it it has risen 623.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $92.4068 per EA |
|---|---|
| All-time high | $92.6526 (May 14, 2025) |
| All-time low | $12.7707 (Nov 28, 2013) |
| 52-week high | $92.4068 |
| 52-week low | $92.2966 |
| Median price | $57.3459 |
| Average price | $58.9597 |
| Largest weekly change | +20.9% (Oct 8, 2014) |
| Weeks tracked | 619 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+0.2%
3Y
+20.9%
5Y
+38.1%
All
+623.6%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of WELLBUTRIN XL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for WELLBUTRIN XL 300 MG TABLET, manufactured by Bausch Health US LLC, is $92.4068 per EA (NDC 00187073130), effective Oct 1, 2025.
How has the price of WELLBUTRIN XL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for WELLBUTRIN XL 300 MG TABLET has risen 623.6%. It has been tracked across 619 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for WELLBUTRIN XL 300 MG TABLET?
Since Nov 28, 2013, the NADAC for WELLBUTRIN XL 300 MG TABLET has ranged from a low of $12.7707 (Nov 28, 2013) to a high of $92.6526 (May 14, 2025), with a median of $57.3459 per EA.
Are there cheaper alternatives to WELLBUTRIN XL 300 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 300 MG TABLET, is $0.1014 per EA — about 99% below WELLBUTRIN XL 300 MG TABLET.
Who manufactures WELLBUTRIN XL 300 MG TABLET?
WELLBUTRIN XL 300 MG TABLET (NDC 00187073130) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.